Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies Read more
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist Read more
Datopotamab Deruxtecan BLA Submitted for Accelerated Approval in the U.S. for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Read more
Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia Read more
Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Read more
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk Read more
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases Read more
GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline Read more